Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиAquestive Therapeutics Мультипликаторы 2011-2024 | AQST
Мультипликаторы по годам Aquestive Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-32.6 | -0.8 | -2.1 | -3.2 | -1.5 | -2.4 | - | - | - | - | - | - | - |
P/S |
5.1 | 0.9 | 2.9 | 3.9 | 1.9 | 2.2 | - | - | - | - | - | - | - |
EPS |
-0.1 | -1.1 | -1.9 | -1.7 | -2.6 | -3.0 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
397 млн | 189 млн | 264 млн | 258 млн | 137 млн | 164 млн | 69.6 млн | 57 млн | - | - | - | - | - |
EBITDA per Share |
-0.22 | -0.81 | -0.83 | -1.17 | -1.96 | -2.2 | - | - | - | - | - | - | - |
EV/EBITDA |
-7.3 | -4.7 | -2.3 | -2.9 | - | - | - | - | - | - | - | ||
PEG |
- | -0.2 | -0.13 | 0.0 | - | - | - | - | - | - | - | ||
P/B |
-2.4 | -0.3 | -1.8 | -3.7 | -16.6 | 14.7 | - | - | - | - | - | - | - |
P/CF |
-40.2 | -4.2 | -4.5 | -3.9 | -1.7 | -10.0 | - | - | - | - | - | - | - |
ROE % |
7.39 | 45.89 | 85.88 | 115.02 | 1082.10 | -608.89 | - | - | - | - | - | - | - |
ROA % |
-13.71 | -95.34 | -113.79 | -88.71 | -84.41 | -70.67 | - | - | - | - | - | - | - |
ROCE % |
14.18 | 35.48 | 42.22 | -102.66 | -87.89 | -90.79 | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.3 | 0.4 | 2.1 | 3.7 | 2.3 | - | - | - | - | - | - | - |
DSO |
- | - | - | 55.4 | 91.1 | 35.1 | - | - | - | - | - | - | - |
DIO |
109.9 | 92.4 | - | 69.3 | 51.3 | 94.6 | - | - | - | - | - | - | - |
DPO |
165.3 | 171.9 | - | 199.6 | 220.0 | 355.4 | - | - | - | - | - | - | - |
Операционный цикл |
109.9 | 92.4 | - | 124.7 | 142.3 | 129.7 | - | - | - | - | - | - | - |
Финансовый цикл |
-55.4 | -79.5 | - | -74.9 | -77.7 | -225.7 | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Aquestive Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.03 | -0.1 | 0.15 | - | -0.23 | -0.36 | -0.32 | - | -0.37 | -0.33 | -0.41 | -0.6 | -0.49 | -0.07 | -0.49 | -0.48 | -0.74 | -0.82 | -0.59 | -0.56 | -0.64 | -1.9 | 0.27 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.03 | -0.07 | -0.08 | - | -0.16 | -0.27 | -0.22 | - | -0.15 | -0.16 | -0.22 | - | -0.34 | 0.06 | -0.39 | - | -0.35 | -0.69 | -0.49 | - | -0.36 | -1.66 | 0.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
11.65 | 21.30 | 32.79 | 42.74 | 66.86 | 79.35 | 85.43 | 75.45 | 117.44 | 127.45 | 109.26 | 115.02 | 279.43 | 546.05 | 875.64 | 1082.10 | 737.36 | 287.42 | -409.01 | -608.89 | -432.66 | -295.80 | 74.84 | 34.17 | -3.72 | 8.60 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-24.60 | -45.36 | -58.58 | -70.95 | -93.24 | -67.97 | -86.46 | -64.48 | -96.87 | -100.90 | -86.12 | -88.71 | -72.42 | -69.56 | -91.93 | -84.41 | -84.37 | -78.22 | -94.15 | -70.67 | -77.90 | -40.98 | -12.64 | -17.36 | 5.92 | -13.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
18.68 | 24.58 | 33.88 | 31.91 | 45.11 | 50.11 | 48.98 | 41.78 | 70.20 | 85.41 | 72.48 | 56.18 | 235.90 | 387.19 | 693.27 | 698.53 | 607.21 | 336.18 | -293.56 | -363.16 | -378.36 | -302.23 | 28.16 | -9.27 | -9.27 | 5.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.3 | 0.4 | 0.3 | 0.3 | - | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.9 | 0.9 | 0.9 | 0.9 | 1.1 | 1.1 | 1.1 | 1.1 | 0.6 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.4 | 37.8 | 48.4 | 21.7 | 12.0 | 46.2 | 20.8 | 25.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
123.9 | 89.2 | 122.9 | - | 66.3 | 40.3 | 93.8 | - | 59.1 | 57.6 | 87.0 | 80.5 | 75.4 | 63.5 | 66.3 | 38.4 | 56.2 | 48.1 | 108.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
196.7 | 159.5 | 215.6 | - | 109.2 | 74.0 | 182.0 | - | 148.4 | 151.1 | 228.0 | 232.0 | 217.2 | 182.8 | 241.4 | 164.9 | 241.2 | 206.6 | 425.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
123.9 | 89.2 | 122.9 | - | 66.3 | 40.3 | 93.8 | - | 59.1 | 57.6 | 87.0 | 80.5 | 75.4 | 63.5 | 66.3 | 38.4 | 56.2 | 48.1 | 131.4 | 37.8 | 48.4 | 21.7 | 12.0 | 46.2 | 20.8 | 25.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
-72.8 | -70.3 | -92.7 | - | -42.9 | -33.7 | -88.2 | - | -89.3 | -93.5 | -140.9 | -151.5 | -141.8 | -119.3 | -175.1 | -126.5 | -185.0 | -158.5 | -294.3 | 37.8 | 48.4 | 21.7 | 12.0 | 46.2 | 20.8 | 25.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD